Physician profile
John D Smith
NPI 1205106036
$1,518.64
in general payments reported to CMS, 2019-2025
11 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.41 · 2022: $251 · 2023: $399 · 2024: $521 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.65 |
| Education | $166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $573.20 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $289.46 | 2024-2025 | Lumryz |
| Harmony Biosciences LLC | $231.84 | 2021-2024 | Wakix |
| Axsome Therapeutics, INC. | $146.04 | 2022-2025 | Sunosi |
| Resmed Corp | $100.82 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $57.14 | 2022-2023 | Quviviq |
| Zoll Respicardia, INC. | $43.32 | 2024-2025 | Remede System |
| Lilly USA, LLC | $25.29 | 2025 | Zepbound |
| Eisai INC. | $22.01 | 2021 | |
| Fisher & Paykel Healthcare INC | $16.73 | 2022 | |
| Edwards Lifesciences Corporation | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.